{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:28:44Z","timestamp":1788175724607,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["QN25H160118"],"award-info":[{"award-number":["QN25H160118"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373183"],"award-info":[{"award-number":["82373183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymthe.2025.12.021","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:14:36Z","timestamp":1765440876000},"page":"1448-1464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-022X","authenticated-orcid":false,"given":"Jiannan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7574-011X","authenticated-orcid":false,"given":"Wenying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.021_bib1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.021_bib2","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2025.12.021_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/humupd\/dmae020","article-title":"Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage","volume":"30","author":"Guo","year":"2024","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ymthe.2025.12.021_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216057","article-title":"Molecular characteristics and clinical behaviour of epithelial ovarian cancers","volume":"555","author":"Hollis","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2025.12.021_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41591-022-02182-7","article-title":"Allogeneic BCMA-targeting CAR T cells in relapsed\/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results","volume":"29","author":"Mailankody","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.12.021_bib6","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(19)30115-2","article-title":"A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial","volume":"6","author":"Yan","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib7","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/DDDT.S413348","article-title":"CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working","volume":"17","author":"Zhu","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ymthe.2025.12.021_bib8","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/cells11223626","article-title":"Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors","volume":"11","author":"Johnson","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.12.021_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215948","article-title":"Metabolic and epigenetic orchestration of (CAR) T cell fate and function","volume":"550","author":"Akbari","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2025.12.021_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2019.1698261","article-title":"Memory T cell, exhaustion, and tumor immunity","volume":"43","author":"Ando","year":"2020","journal-title":"Immunol. Med."},{"key":"10.1016\/j.ymthe.2025.12.021_bib11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cancers14061550","article-title":"Mesothelin: An Immunotherapeutic Target beyond Solid Tumors","volume":"14","author":"Faust","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.12.021_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005691","article-title":"Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models","volume":"11","author":"Schoutrop","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.021_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/cancers15051357","article-title":"Challenges of Anti-Mesothelin CAR-T-Cell Therapy","volume":"15","author":"Zhai","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.12.021_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00262-022-03238-w","article-title":"Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer","volume":"72","author":"Chen","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.12.021_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1288383","article-title":"CAR-T treatment for cancer: prospects and challenges","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.021_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.021_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2025.12.021_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309094","article-title":"A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-Mediated Synergistic Antitumor Metabolic and Immune Therapy","volume":"36","author":"Jin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2025.12.021_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf9522","article-title":"Mitochondrial metabolic flexibility is critical for CD8+ T cell antitumor immunity","volume":"9","author":"Chen","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.12.021_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","article-title":"FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy","volume":"629","author":"Chan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.021_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","article-title":"FOXO1 is a master regulator of memory programming in CAR T cells","volume":"629","author":"Doan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.021_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.it.2020.06.002","article-title":"The Contribution of Epigenetics to Cancer Immunotherapy","volume":"41","author":"Villanueva","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.12.021_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.09.014","article-title":"Modification of Proteins by Metabolites in Immunity","volume":"54","author":"Diskin","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.12.021_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114957","article-title":"H3K9 lactylation in malignant cells facilitates CD8+ T cell dysfunction and poor immunotherapy response","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.12.021_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","article-title":"Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduction Target. Ther."},{"key":"10.1016\/j.ymthe.2025.12.021_bib29","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1038\/s41467-023-38414-8","article-title":"Small-sample learning reveals propionylation in determining global protein homeostasis","volume":"14","author":"Shui","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.021_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","article-title":"The role of RNA methylation in tumor immunity and its potential in immunotherapy","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.021_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.021_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","article-title":"Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer","volume":"835","author":"Heers","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj3620755","article-title":"Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase","volume":"362","author":"Silva","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2025.12.021_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006857","article-title":"Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia","volume":"11","author":"Wen","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.021_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph14050475","article-title":"Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes","volume":"14","author":"Lin","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ymthe.2025.12.021_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2019.00569","article-title":"Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma\/Delta T Cells Upon Interaction With Tumor Cells","volume":"10","author":"Bhat","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib37","article-title":"Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib38","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1111\/bph.14837","article-title":"Trichostatin A blocks aldosterone-induced Na+ transport and control of serum- and glucocorticoid-inducible kinase 1 in cortical collecting duct cells","volume":"176","author":"Mansley","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib39","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/s41467-019-13718-w","article-title":"Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress","volume":"10","author":"You","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.021_bib40","article-title":"Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.12.021_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pro.544","article-title":"Structure of Sir2Tm bound to a propionylated peptide","volume":"20","author":"Bheda","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2025.12.021_bib42","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nsmb.3490","article-title":"Histone propionylation is a mark of active chromatin","volume":"24","author":"Kebede","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib43","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","article-title":"Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer","volume":"11","author":"Saatci","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.021_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501765","article-title":"Accurate Neurotransmitter Release by Ultrasound-Responsive Nanomaterials for Alleviating L-DOPA-Induced Dyskinesia in Parkinson\u2019s Disease","volume":"14","author":"Jia","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2025.12.021_bib45","article-title":"Bifidobacterium pseudolongum-Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP-PKG-mTORC1 Pathway","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.12.021_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011044","article-title":"Dual roles of IRE1\u03b1 inhibition in reversing mitochondrial ROS-induced CD8+ T-cell senescence and exerting direct antitumor effects in multiple myeloma","volume":"13","author":"Wan","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.021_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s42003-022-03140-2","article-title":"PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle","volume":"5","author":"Hildebrand","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ncb3148","article-title":"Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer","volume":"17","author":"Ross","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellimm.2015.01.019","article-title":"Modulation of human gamma\/delta T-cell activation and phenotype by histone deacetylase inhibitors","volume":"296","author":"Bhat","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jbt.21513","article-title":"Sodium valproate sensitizes non-small lung cancer A549 cells to \u03b3\u03b4 T-cell-mediated killing through upregulating the expression of MICA","volume":"27","author":"Du","year":"2013","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic Reprogramming of Immune Cells in Cancer Progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.12.021_bib52","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.7150\/thno.62378","article-title":"Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.12.021_bib53","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation."},{"key":"10.1016\/j.ymthe.2025.12.021_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s42003-024-06201-w","article-title":"Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner","volume":"7","author":"Udayasuryan","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2025.12.021_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:17Z","timestamp":1778616437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525001625010445"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}